Weber Barbara
Director, Executive Chair
Weber Barbara has filed 1 SEC Form 4 filing (3 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: Feb 4, 2026.
On the most recent filing, Weber Barbara is listed as Director, Executive Chair at Tango Therapeutics, Inc. Inside the rolling window, Weber Barbara reported no open-market purchases and 1 open-market sale totaling $374K in TNGX.
Companies traded
Other insiders at TNGX
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$374K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Weber Barbara made?
Weber Barbara has filed 1 SEC Form 4 filing (3 transaction rows) across 1 company since 2026.
Which companies does Weber Barbara trade?
Weber Barbara has filed SEC Form 4 disclosures for 1 company, including TNGX.
When was Weber Barbara's most recent SEC Form 4 filing?
Weber Barbara's most recent SEC Form 4 filing on Tracefour is dated Feb 4, 2026.
What is Weber Barbara's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Weber Barbara is listed as Director, Executive Chair.
What is Weber Barbara's total buy and sell value in the current window?
Inside the rolling retention window, Weber Barbara bought $0 and sold $374K based on SEC Form 4 filings.
What was Weber Barbara's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 30,519 TNGX shares on 2026-02-03, worth $374K, per SEC Form 4 filings.